Pathological response to neoadjuvant chemotherapy in the triple negative breast cancers in our patient population

被引：0
|
作者：
Oprea-Ilies, G. M.
Lund, M. L.
Yang, L.
O'Reagan, R.
Bouzryk, M.
Levand-Jones, B.
Mosunjac, M. B.
Panbuccian, S. F.
Gulbahce, H. E.
机构：
[1] Emory Univ, Grady Mem Hosp, Atlanta, GA 30322 USA
[2] Emory Univ, Atlanta, GA 30322 USA
[3] Univ Minnesota, Minneapolis, MN USA
来源：
MODERN PATHOLOGY | 2008年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
209
引用
收藏
页码：48A / 48A
页数：1
相关论文
共 50 条
  • [21] Pathological tumor response to neoadjuvant chemotherapy using anthracycline and taxanes in patients with triple-negative breast cancer
    Sakuma, Kaori
    Kurosumi, Masafumi
    Oba, Hanako
    Kobayashi, Yasuhito
    Takei, Hiroyuki
    Inoue, Kenichi
    Tabei, Toshio
    Oyama, Tetsunari
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2011, 2 (02) : 257 - 264
  • [22] Luminal androgen receptor role and pathological complete response rate to neoadjuvant chemotherapy in triple negative breast cancer
    Chica-Parrado, M. R.
    Santonja, A.
    Lluch-Hernandez, A.
    Albanell, J.
    Sanchez-Munoz, A.
    Chacon, I.
    Calvo, L.
    Sanchez-Rovira, P.
    De la Haba, J.
    Vicioso, L.
    Martin, M.
    Plazaola, A.
    Prat, A.
    Ribelles, N.
    Sanchez-Arago, M.
    Jerez, J. M.
    Escudero, M. J.
    Caballero, R.
    Carrasco, E.
    Alba Conejo, E.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [23] The impact of chemotherapy relative dose intensity on pathological complete response in patients with triple negative breast cancer treated with neoadjuvant chemotherapy
    Buonaiuto, Roberto
    Neola, Giuseppe
    Caltavituro, Aldo
    Trasacco, Paola
    Mangiacotti, Federica Pia
    Pecoraro, Giovanna
    Lambertini, Matteo
    Pietroluongo, Erica
    De Placido, Pietro
    De Placido, Sabino
    Forestieri, Valeria
    Giuliano, Mario
    Arpino, Grazia
    De Angelis, Carmine
    [J]. CANCER RESEARCH, 2024, 84 (09)
  • [24] Responses rates and outcome to neoadjuvant chemotherapy in triple-negative breast cancers (TNBC)
    Neciosup, S. P.
    Ventura, L.
    Gomez, H.
    Pinto, J. A.
    Marcelo, M. J.
    Vidaurre, T.
    Vallejos Sologuren, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [25] Genomic change in residual triple-negative breast cancers after neoadjuvant chemotherapy
    Aguilar-Mahecha, Adriana
    Przybytkowski, Ewa
    Lafleur, Josiane
    Lan, Cathy
    Legare, Stephanie
    Alirezaie, Najmeh
    Seguin, Carole
    Discepola, Federico
    Kovacina, Bojan
    Mihalcioiu, Catalin
    Robidoux, Andre
    Marcus, Elizabeth
    Roy, Josee Anne
    Pelmus, Manuela
    Aleynikova, Olga
    Nabavi, Sheida
    Majewski, Jacek
    Basik, Mark
    [J]. CANCER RESEARCH, 2015, 75
  • [26] The immune landscape of residual triple-negative breast cancers after neoadjuvant chemotherapy
    Gonzalez-Ericsson, Paula I.
    Sanchez, Violeta
    Salgado, Roberto
    Bordeaux, Jennifer
    Kim, Ju Y.
    Vaupel, Christine
    Gomez, Henry
    Sanders, Melinda E.
    Balko, Justin M.
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [27] Prediction of pathological complete response to neoadjuvant chemotherapy in early triple negative breast cancer patients by serial breast ultrasound examination
    Rapoport, Bernardo
    Smit, Teresa
    Heyman, Liezl
    Moosa, Farhana
    Benn, Carol Ann
    [J]. CANCER RESEARCH, 2021, 81 (04)
  • [28] Association between pathological response and tumor genomic profiling in triple negative breast cancer patients treated with neoadjuvant chemotherapy
    Ademuyiwa, Foluso O.
    Luo, Jingqin
    Fisk, Bryan
    Jeffers, Gejae
    Summa, Tracy
    Grigsby, Isabella
    Rimawi, Mothaffar
    Anurag, Meenakshi
    Ellis, Matthew
    Griffith, Obi
    Griffith, Malachi
    [J]. CANCER RESEARCH, 2021, 81 (04)
  • [29] A Predictor of Pathological Complete Response to Neoadjuvant Chemotherapy Stratifies Triple Negative Breast Cancer Patients with High Risk of Recurrence
    Fournier, Marcia, V
    Goodwin, Edward C.
    Chen, Joan
    Obenauer, John C.
    Tannenbaum, Susan H.
    Brufsky, Adam M.
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [30] A Predictor of Pathological Complete Response to Neoadjuvant Chemotherapy Stratifies Triple Negative Breast Cancer Patients with High Risk of Recurrence
    Marcia V. Fournier
    Edward C. Goodwin
    Joan Chen
    John C. Obenauer
    Susan H. Tannenbaum
    Adam M. Brufsky
    [J]. Scientific Reports, 9
12345